• PSYCHSPACE
  • Posts
  • 👁️ Is the DEA Banning More Psychedelics?

👁️ Is the DEA Banning More Psychedelics?

Mike Tyson has a new mushroom growing kit on the market 🍄

Did you know Ayahuasca, rooted in the Amazon rainforest, has been utilized for thousands of years by indigenous tribes?

This powerful brew, typically consumed under the guidance of a seasoned shaman, is renowned for spiritual awakening, healing, and deep introspection.

It consists of Banisteriopsis caapi vine, which contains harmala alkaloids essential for activating DMT, and Psychotria viridis leaves, rich with DMT that works with the vine to unlock Ayahuasca's profound journey.

While its use began within the Amazon, the growing interest worldwide speaks to its universal appeal and the quest for deeper meaning and healing.

What are the two main ingredients of Ayahuasca? 🌿

Login or Subscribe to participate in polls.

Gotta Blast 🚀:

  • UNM Health Sciences researchers are exploring new psychedelic studies to treat mental health.

  • SSDP challenges DEA’s proposal to ban DOI and DOC, arguing it hinders promising psychedelic research.

  • Mike Tyson launches ‘Mikeadelics,’ a magic mushroom kit, marking his entry into the psychedelic market.

Quote of the Week 📖:

Every person’s body chemistry is different. The effect of one single drug that appeals to me might have a different effect on someone else. There’s no way to tell what the perfect psychedelic drug would be because it would be perfect for only you.

— Ann Shulgin, Psychedelic Researcher and Author

CHANGING MINDS🧠

UNM’s Psychedelic Revolution 🔬

Researchers at the University of New Mexico Health Sciences, like Dr. Larry Leeman, are pioneering two new psilocybin studies. The RECONNECT study is exploring RE104, a novel compound related to psilocybin, as a potential rapid treatment for postpartum depression. Meanwhile, the uAspire study is assessing psilocybin’s benefits for major depressive disorder, ensuring that participants can access treatment regardless of initial results.

Leeman’s team is also investigating MDMA-assisted therapy for postpartum mothers with opioid use disorder. The goal is to alleviate PTSD symptoms that often drive drug use, with sessions facilitated by trained therapists.

At the Interdisciplinary Substance Use and Brain Injury Center (ISUBI), the team can safely conduct these trials, providing supportive environments for participants.

These innovative studies highlight UNM Health Sciences' commitment to advancing the understanding and treatment of behavioral health issues through psychedelic research.

More in the Space 👁️

👁️ Worldwide Clinical Trials, PI-House, and the Polish Psychedelic Society team up for Poland's first industry-sponsored psychedelic studies.

👁️ Eulas opens Scotland's first clinic for cutting-edge psychedelic therapies, aiming to revolutionize mental health care.

MOVING THE NEEDLE🪡

DEA’s Psychedelics Ban: A Disservice to Science?🧪

Students for Sensible Drug Policy (SSDP) is fighting back against the DEA’s plan to classify 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) as Schedule I drugs.

SSDP argues that this move would block important research and isn't backed by the evidence. In a statement to the DEA’s court, they point out that neither drug has a high abuse potential, nor are there any serious side effects documented.

These psychedelics have shown promise in treating conditions like chronic pain and opioid addiction (plus much more). Over 35 years of research, including studies funded by federal health agencies, support their benefits. Banning these compounds would not only slow scientific progress but also prevent potential breakthroughs in mental health treatment.

There is a plethora of evidence demonstrating that DOI does not have significant potential for abuse yet the DEA continues on an anti-scientific tirade of ignoring facts

Elijah Ullman, SSDP’s Science Policy Committee Chair

While the DEA claims these substances are dangerous, scientists argue that the lack of major adverse events reported in medical literature does not support their classification as Schedule I drugs. SSDP insists the DEA’s actions undermine scientific research and the potential for medical advancements.

What do you think? 🤔

More in the Space 👁️

👁️ Veterans push for MDMA therapy, but FDA's skepticism may delay approval despite advocacy efforts.

👁️ Mike Tyson launches ‘Mikeadelics’ magic mushroom kit, entering the psychedelic market.

👁️ Psychedelic drug market projected to hit $4.6 billion by 2030!

COMMUNITY PULSE 🌐

Think About It GIF by Identity

LET’S LEARN

It’s always nice when we get to witness transformational stories about how psychedelics save people’s lives, especially when all hope is lost.

Whether it’s battling addiction, saving a marriage, or finding pieces of your soul — sometimes we just need a little guidance from our 🍄 friends.

Here’s a woman who was saved by psychedelic therapy.

Here’s a couple who credits psychedelics to a 50-year marriage!

Enjoy!

PODCASTS/VIDEOS:

EVENTS/COURSES/RETREATS:

PsyCon Psychedelic Convention

📅 Dates: October 10-12, 2024

Denver Convention Center

PsyCon is the premier trade show and expo for Colorado’s emerging psychedelic industry. Featuring the top names in psychedelic science presenting the latest cutting-edge research, PsyCon offers entrepreneurs and consumers alike the chance to learn, network, and build the foundation for what could soon be one of the biggest psychedelic markets in the nation.

Psychedelic Medicine Preparation & Integration Certification

📅 Dates: Begins October 15th, 2024

Hybrid

A 6-month journey with video lectures, live Zoom sessions, reading assignments, forum discussions, and an in-person intensive in Costa Rica. Gain expertise in the pharmacology, history, and applications of 8+ psychedelic medicines, intercultural perspectives, ethics, and specific treatment opportunities. Earn certification in Embodied Imagination® for Psychedelic Integration and attend a 5-day practicum retreat in Costa Rica. Train to confidently support clients before and after their transformative journeys.

Limited spaces available—secure your spot now!

BEFORE WE GO😢

Thank you for reading and being a part of this psychedelic journey! 🍄

👁️ Are you a psychedelic therapist/coach, retreat center, or brand looking to elevate your content? PSYCHSPACE Creations is here to help. Book a consultation call with us today and let’s bring your vision to life!

👁️ Have a question or want to build a partnership? Message us! [email protected]

How'd You Trip with Today's Read?

Login or Subscribe to participate in polls.

Reply

or to participate.